Linical Co., Ltd. (JP:2183) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Linical Co., Ltd. reported a decline in net sales for the first half of 2024, with a 10.5% decrease compared to the same period in 2023, leading to a loss in profit attributable to owners of the parent. Despite the decrease in financial performance, the company maintains a stable shareholder equity ratio of 42.7%. Looking forward, Linical forecasts a further decline in profits for the full fiscal year ending March 2025.
For further insights into JP:2183 stock, check out TipRanks’ Stock Analysis page.